ZS Pharma

Committed to Advancing Patient Care

  • Developing New Therapies to Improve the Treatment of HyperkalemiaThe core of our R&D program is to develop safe and efficacious treatments
    for patients with serious conditions using a novel selective ion-trap technology
  • Partnering with Clinicians to Advance Hyperkalemia TreatmentZS Pharma is committed to improving patient outcomes by developing
    novel therapies to treat life threatening conditions, such as hyperkalemia
  • Our Commitment to the PatientZS Pharma is committed to improving patient outcomes and care by
    developing novel therapies to treat and manage hyperkalemia
Developing New Therapies to Improve the Treatment of Hyperkalemia1 Partnering with Clinicians to Advance Hyperkalemia Treatment2 Our Commitment to the Patient3

Our Commitment

ZS Pharma is committed to advancing patient care by developing new therapeutic compounds to treat serious conditions related to kidney, cardiovascular and liver diseases. Our lead investigational therapy, ZS-9, is a novel agent for the treatment of hyperkalemia, a potentially life-threatening condition characterized by abnormally high levels of potassium in the blood.

We are evaluating ZS-9 in a late-stage clinical trial program to demonstrate its ability to safely, effectively and rapidly remove excess potassium from the body. Learn more about our positive top-line results from the pivotal Phase 3 clinical trial in patients with hyperkalemia here.

Stay in the Know

Keep up to date with the latest ZS Pharma News and Updates

Sign Up

Recent News

March 27, 2014

ZS Pharma to Present Results of Phase 2 Trial of ZS-9 at 2014 American College of Cardiology’s Annual Scientific Session

Download PDF

March 25, 2014

ZS Pharma Announces Start of Enrollment of Phase 3 Extended Dosing Study of ZS-9 in Patients with Hyperkalemia

Download PDF

March 5, 2014

ZS Pharma Completes $55 Million Financing to Advance Its Novel Investigational Treatment for Hyperkalemia

Download PDF
X

Keep up to date with the latest ZS Pharma News and Updates